These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 29070105)

  • 1. [Embelin Reverses the Multi-drug Resistance of K562/D to Daunorubicin Independently of P-gp and MDR1 mRNA].
    Jiang HN; Liu ZG; Hu R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1342-1349. PubMed ID: 29070105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.
    Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M
    Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The study on reversing mechanism of multidrug resistance of K562/A02 cell line by curcumin and erythromycin].
    Chang HY; Pan KL; Ma FC; Jiao XY; Zhu HF; Liu JH; Huang Y; Cao YH
    Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):254-8. PubMed ID: 16875558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on reversal effect of nilotinib in combination with 5-BrTet on multidrug resistance of K562/A02 cell line].
    Chen BA; Shan XY; Chen J; Wang F; Ding JH; Gao C; Zhao G; Wang XM; Xu WL; Gao F; Xia GH; Schmitt M
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):385-8. PubMed ID: 21122353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of PDMP, a glucosylceramide synthase inhibitor, on reversion of daunorubicin resistance in human leukemia cell line K562/A02].
    Yin L; Chen BA; Cheng J; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Gao F; Song HH; Bao W; Wu WW; Wang F; Liang YQ; Xia GH; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):79-84. PubMed ID: 20137123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inducing apoptosis and reversal effect of nilotinib in combination with tetrandrine on multidrug resistance of K562/A02 cell line].
    Cui TY; Chen BA; Ding JH; Gao C; Cheng J; Bao W; Zhong YJ; Shan XY; Gao F; Xia GH; Schmitt A; Schmitt M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):28-33. PubMed ID: 21362216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of converting K562/DNR cellular drug-resistance by bortezomib.
    Li YC; Wang HH; Liao AJ; Fu BB; Zhang R; Li J; Yang Y; Liu ZG; Yang W
    Eur Rev Med Pharmacol Sci; 2014; 18(10):1465-72. PubMed ID: 24899604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of 5-bromotetrandrine and daunorubicin on apoptosis and expression of survivin in K562/A02 cells].
    Cai XH; Chen BA; Cheng J; Wang J; Ding JH; Bao W; Zhong YJ; Gao F; Xu WL; Shen HL; Wei HL; Chen J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):24-7. PubMed ID: 21362215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cells.
    Chen BA; Mao PP; Cheng J; Gao F; Xia GH; Xu WL; Shen HL; Ding JH; Gao C; Sun Q; Chen WJ; Chen NN; Liu LJ; Li XM; Wang XM
    Int J Nanomedicine; 2010 Aug; 5():437-44. PubMed ID: 20957165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome inhibitor bortezomib overcomes P-gp-mediated multidrug resistance in resistant leukemic cell lines.
    Zheng B; Zhou R; Gong Y; Yang X; Shan Q
    Int J Lab Hematol; 2012 Jun; 34(3):237-47. PubMed ID: 22145750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
    Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
    Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of mifepristone on reversing multidrug resistance of leukemic cell line K562/A02].
    Kong DX; Chen CY; Xu FY; Jia JH
    Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):555-9. PubMed ID: 18078134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of bortezomib on MAPK signaling pathway of K562/DNR cells].
    Liao AJ; Fu BB; Wang HH; Li YC; Yao K; Zhang R; Yang W; Liu ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1460-3. PubMed ID: 21176351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on reversing mechanism of multidrug resistance of K562/A02 cell line by carnosic acid].
    Yu XN; Li H; Chen XL; Li XX; Wang R; Gao F
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):381-4. PubMed ID: 21122352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Orphanin FQ combined with adriamycin reverses multi-drug resistance of K562/ADM and its molecular mechanism].
    Wang XX; Liu XQ; Zhang W; Chen X; Zhao L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):574-8. PubMed ID: 22739158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2.
    Li H; Hui L; Xu W
    Acta Biochim Biophys Sin (Shanghai); 2012 Mar; 44(3):269-77. PubMed ID: 22285729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of tetrandrine and 5-bromotetrandrine in reversing multidrug resistance may relate to down-regulation of multidrug resistance associated protein 7 expression.
    Cheng J; Dai JY; Chen BA; Cai XH; Wang S; Gao F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):558-63. PubMed ID: 22739155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells.
    Nielsen D; Eriksen J; Maare C; Friche E; Skovsgaard T
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):453-60. PubMed ID: 12107549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of multidrug resistance in xenograft nude-mice by magnetic Fe(3)O(4) nanoparticles combined with daunorubicin and 5-bromotetrandrine.
    Wu YN; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):60-4. PubMed ID: 19236748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.